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Abstract
Background: The C242T polymorphism of the CYBA gene that encodes p22phox, a component of NADPH oxidase, has been
found to modulate superoxide production. Oxidase is a major source of the superoxide anion that contributes to individual
components of metabolic syndrome. We examined the relationship of the C242T polymorphism with the prevalence of
metabolic syndrome in a Chinese population, taking account of consumed cigarette amounts.
Methodology/Principal Findings: In 870 participants, we collected biomarkers related to metabolic syndrome and detailed
history of smoking and genotyped the C242T polymorphisms. After adjustment for covariates, the CT/TT genotypes were
associated with a lower risk of metabolic syndrome (P=0.0008). The odds of having metabolic syndrome in the CT/TT
participants were 0.439 (95%CI: 0.265, 0.726), while for CC participants the odds were 1.110 (95%CI: 0.904, 1.362). There was
significant (P=0.014) interaction between the C242T polymorphism and smoking status in relation to the prevalence of
metabolic syndrome. For smokers who smoke no less than 25 pack-years, those with CT/TT genotypes had lower risk of
metabolic syndrome as compared with CC polymorphism carriers (P=0.015). In the multiple regression analysis, the CT/TT
genotypes were significantly associated with lower serum concentration of triglycerides both in all subjects and smokers;
furthermore, the CT/TT genotypes were also related to smaller waist circumference in smokers.
Conclusions: Our study suggests that the C242T gene polymorphism is indeed related to the prevalence of metabolic
syndrome and smoking dose might modify this association.
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Introduction
Metabolic syndrome is defined as a cluster of metabolic
abnormalities that increases the risk for type 2 diabetic mellitus,
coronary artery disease (CAD) and other cardiovascular diseases.
The core components of metabolic syndrome are high blood
pressure, central obesity, impaired fasting glucose and dyslipide-
mia [1]. Recently, high levels of oxidative stress and reduced
production of anti-inflammatory were reported to be associated
with metabolic syndrome [2].
Nicotinamide adenine dinucleotide phosphate (NADPH) oxi-
dase, a multisubunit protein complex consisting of membrane-
bound and cytosolic subunits, is a major source of superoxide
anion in the vasculature [3]. The p22phox subunit is essential for
activation of the NADPH oxidase system [4]. Several polymor-
phisms of the CYBA gene have been identified. Among these, the
C242T polymorphism is located on chromosome16q24, exon4, at
position 242 of the CYBA gene, and results in the amino acid
substitution of tyrosine for histidine at residue 72 within one of the
two heme-binding sites [5]. The functional significance of the
C242T polymorphism has been related to NADPH oxidase
activity with subsequent production of the superoxide anion [6,7].
However, it is not yet clarified how it begins and how the
genetic and environmental factors influence different components
of metabolic syndrome. We tested the hypothesis that the C242T
polymorphism in the CYBA gene is related to the prevalence of
metabolic syndrome in a cross-sectional study. As smoking may
influence vascular NADPH oxidase activation [8–11], we further
examined whether smoking dose could modify the genetic effect in
a Chinese population.
Methods
Ethics statement
The Institutional Review Board of Changzhou Second People’s
Hospital, Affiliated Nanjing Medical University approved the
study protocol.
Study population
All participants of the present study were recruited from the
Centre for Medical Examinations in Changzhou Second People’s
Hospital, affiliated Nanjing Medical University of China, which
provides service of comprehensive health examinations for adults
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or acute symptoms, but may have chronic diseases such as
hypertension. We did not apply any inclusion or exclusion criteria
for our study. All subjects gave informed written consent.
In the periods from January 2011 to May 2011, we examined
882 subjects, who volunteered participating in our study. 12
subjects were excluded from the present analysis because of
missing information on biochemical measurements (n=7) or
genotypes (n=5). Thus, the number of subjects statistically
analyzed added up to 870.
Clinical and biochemical measurements
Experienced observers used a standardized questionnaire to
collect information on smoking history (duration and daily
consumption of cigarettes), consumption of alcohol, complete
medical history and use of medications. Smoking habit was
defined as smoking more than 1 cigarette a day for at least 1 year,
or more than 360 cigarettes a year. Pack-years were calculated by
multiplying the number of packs of cigarettes smoked a day by the
number of years the person had smoked. The level of inhalation
(pack-years) was categorised into four levels: ,10 pack-years,
10,,19 pack-years, 19,,25 pack-years, $25 pack-years.
Alcohol habit was defined as drinking more than twice a week,
consumption of more than 50 ml of heavy liquor or 500 ml of beer
on each occasion. Each participant’s blood pressure was measured
three times consecutively by conventional sphygmomanometry
after the participants had rested for at least 5 minutes in the sitting
position. These three readings were averaged for analysis. The
body weight, body height, and waist and hip circumferences were
measured. The body mass index was calculated as the ratio of the
body weight in kilograms to the square of the height in meters, and
the waist-to-hip ratio was the smallest circumference at the waist
divided by the largest circumference at the hip.
After overnight fasting, a venous blood sample was drawn for
the measurement of plasma glucose and serum total cholesterol,
HDL cholesterol and triglycerides by an automated enzymatic
method (Chemistry Analyzer AU640, Olympus Medical Engi-
neering Company, Tokyo, Japan). LDL cholesterol concentration
was calculated using the Friedewald formula [12].
Definition of metabolic syndrome
We defined the metabolic syndrome according to the IDF
criteria [13]. The metabolic syndrome was diagnosed, if a subject
had abdominal obesity defined as elevated waist circumference
$90 cm among men or $80 cm among women for Chinese
population, and had at least two of the four following
characteristics: 1) triglycerides $150 mg/dL (1.7 mmol/L); 2)
HDL cholesterol ,40 mg/dL (1.03 mmol/L) in men and
,50 mg/dL (1.29 mmol/L) in women or specific treatment for
these lipid abnormalities; 3) blood pressure $130/85 mmHg or
the use of antihypertensive drugs; and 4) fasting glucose
$100 mg/dL (5.6 mmol/L) or the presence of diabetes mellitus.
DNA isolation and genotyping of C242T polymorphism
Whole venous blood was drawn into ethylenediamine tetra-
acetic acid tubes and then stored at 280uC. Genomic DNA
was extracted from white blood cells using a commercially
available kit and the BioRobot M48 Workstation (Qiagen
Inc., Hilden, Germany) according to the manufacturer’s instruc-
tions. Polymerase chain reaction (PCR) for the C242T polymor-
phism was performed in 384-well plates following a standard
protocol [14] for TaqMan MGB probes. After the PCR was
finished, endpoint fluorescence was measured, and allelic discrim-
ination was performed using a PRISMH 7900HT Sequence
Detection System (ABI) and a LightCyclerH 480 Real-Time PCR
System (Roche).
Statistical analysis
For database management and statistical analysis, we used SAS
software, version 9.1.3 (SAS Institute, Cary, North Carolina,
USA). We reported the central tendency and spread of normally
and non-normally distributed data as the mean 6 standard
deviation (SD) and as the median with the interquartile range,
respectively. Hardy-Weinberg equilibrium was assessed using
the chi-square test. We compared the means and proportions
using t-test, the one-way analysis of variance (ANOVA) and the
chi-square test, respectively. Logistic regression was used to
examine the relationship between the C242T polymorphism and
prevalence of metabolic syndrome, and to explore the interac-
tion between smoking and the C242T polymorphism in relation
to prevalence of metabolic syndrome as well. To select vari-
ables (potential confounders) for the models, we first used the
univariate linear regression method to filter out variables that
associate with prevalence of metabolic syndrome which included
age, sex, body height, body weight, alcohol intake and heart
rate. As various medications and smoking may influence the
NADPH oxidase, antihypertensive medication, antidiabetic med-
ication and smoking were also included. Therefore, the variables
mentioned above were finally used as covariates in the regression
models. Dominant models (major homozygous genotype as a
reference) were typically used. P,0.05 was considered statistically
significant.
Results
Characteristics of the participants
The study population included 342 (39.3%) men and 379
(43.6%) hypertensive patients, of whom 94 (24.8%) took
antihypertensive medication. Men, compared with women,
reported a higher proportion of smoking (P,0.0001). The
characteristics of the subgroups stratified by C242T genotype
among smokers and nonsmokers are shown in Table 1. LDL
cholesterol concentration and male sex ratio differed significantly
across genotypes among nonsmokers. While among smokers, waist
circumference and serum concentration of triglycerides were
greater in subjects with the CC genotype.
Genotype frequencies
The C allele frequency was 0.93 in the entire study population
as well as the subgroups stratified by smoking status. The
allele frequencies were in line with the Hardy–Weinberg
equilibrium (x
2=2.43, P=0.12). The allele frequencies among
smokers and nonsmokers did not differ from the corresponding
frequency for the entire population (P=0.29 and P=0.28
respectively).
Association between C242T polymorphism and
prevalence of metabolic syndrome
In logistic regression, after adjustment for covariates, the CT/
TT genotypes were associated with a lower risk of metabolic
syndrome (P=0.0008, Fig. 1A). The odds of having metabolic
syndrome in the CT/TT participants was 0.439 (95%CI: 0.265,
0.726), while for CC participants, the odds was 1.110 (95%CI:
0.904, 1.362).
There was significant (P=0.014) interaction between the
C242T polymorphism and smoking status in relation to the
prevalence of metabolic syndrome. For smokers, the subjects with
CT/TT genotypes had lower risk of metabolic syndrome as
Smoking, Metabolic Syndrome and C242T Polymorphism
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(95%CI: 0.824, 1.776), P=0.0016, Fig. 1B). Whereas for non-
smokers, no significant difference was found between subjects with
CT/TT genotypes and CC carriers (0.571 (95%CI: 0.324, 1.005)
vs. 1.07 (95%CI: 0.841, 1.365), P=0.06). No such interaction was
found between C242Tpolymorphism and gender (P=0.068). In
further stratified analysis, we observed a significant association of
C242T polymorphism with the prevalence of metabolic syndrome
in male smokers (P=0.016), while such relationship was not
observed in male non-smokers (P=0.09).
The significant association between the C242T polymorphism
and the prevalence of metabolic syndrome was further found in
subjects who smoke no less than 25 pack-years (0.217 (95%CI:
0.026, 0.474) vs. 1.345 (0.614, 2.946), P=0.015, Fig. 2). While no
such relationship was found in ,10 pack-years group (0.623
(95%CI: 0.070, 5.574) vs. 1.167 (95%CI: 0.517, 2.630), P=0.84,
Fig. 2), 10,,19 pack-years group (0.322 (95%CI: 0.037, 2.789)
vs. 1.155 (95%CI: 0.538, 2.480), P=0.51, Fig. 2) or 19,,25
pack-years group (0.288 (95%CI: 0.058, 1.429) vs. 1.274 (95%CI:
0.597, 2.719), P=0.78, Fig. 2).
Table 1. Characteristics of the study groups stratified by genotype among smokers and nonsmokers.
Variables Non-smokers P Smokers P
CC (n=541) CT+TT (n=73) CC (n=217) CT+TT (n=39)
Age (years) 46.464.4 46.464.2 0.90 46.664.4 46.564.3 0.85
Height (cm) 158.266.7 158.966.9 0.45 167.966.4 167.267.0 0.57
Waist circumference(cm) 82.069.0 82.568.9 0.63 87.369.5 84.268.2 0.041
Body mass index (kg/m
2) 25.163.2 25.263.1 0.81 25.563.0 24.462.7 0.06
Waist-to-hip ratio 0.8560.06 0.8560.06 0.80 0.8960.06 0.8760.05 0.13
Heart rate (beats/min) 74.768.9 74.2610.3 0.65 71.969.1 73.968.6 0.22
Systolic blood pressure (mm Hg) 131.7616.6 129.3614.7 0.22 134.1614.9 137.6617.4 0.20
Diastolic blood pressure (mm Hg) 85.2610.0 84.7610.0 0.67 88.7610.2 88.1610.1 0.12
Serum glucose (mmol/l) 5.6061.03 5.6761.65 0.74 5.9161.71 6.0561.15 0.53
Triglycerides (mmol/l)
* 1.21(0.85–1.76) 1.17(0.90–1.60) 0.76 1.36(0.85–2.11) 1.19(0.76–2.04) 0.012
Total cholesterol (mmol/l) 4.7960.90 5.0061.02 0.07 5.0861.04 5.0161.08 0.71
HDL cholesterol (mmol/l) 1.3160.28 1.2960.29 0.73 1.2360.32 1.3160.39 0.16
LDL cholesterol (mmol/l) 2.8660.66 3.0360.72 0.04 3.0960.75 2.9160.75 0.18
Male sex, n (%) 78 (14.4) 19 (26.0) 0.02 210 (96.8) 35 (89.7) 0.27
Alcohol intake, n (%) 26 (4.8) 7 (9.6) 0.10 117 (53.9) 25 (64.1) 0.11
Hypertension, n (%) 209 (38.6) 24 (32.9) 0.28 123 (56.7) 23 (59.0) 0.47
Diabetes, n (%) 35 (6.5) 4 (5.5) 0.70 20 (9.2) 5 (12.8) 0.42
HDL=high-density lipoprotein; LDL=low-density lipoprotein.
*The values are the median (interquartile range).
doi:10.1371/journal.pone.0031926.t001
Figure 1. Difference of prevalence of metabolic syndrome between C242T genotypes in all participants and smokers. The odds of
prevalence of metabolic syndrome in genotypic group is expressed relative to the overall risk of all participants (A) or smokers (B), and adjusted for
age, sex, body height, body weight, antihypertensive medication, antidiabetic medication, current smoking, alcohol intake and heart rate. Vertical
lines denote 95% confidence intervals. For each genotype, the number of participants is given.
doi:10.1371/journal.pone.0031926.g001
Smoking, Metabolic Syndrome and C242T Polymorphism
PLoS ONE | www.plosone.org 3 March 2012 | Volume 7 | Issue 3 | e31926Association between C242T polymorphism and the
individual components of the metabolic syndrome
In the multiple regression analysis, the CT/TT genotypes were
significantly associated with lower serum concentration of
triglycerides both in all subjects and smokers, furthermore, the
CT/TT genotypes were also related to smaller waist circumfer-
ence in smokers. While for non-smokers, there was no such
relationship (Table 2).
After exclusion of 111 patients on various medications that may
modulate NADPH oxidase activities, our findings remained
unaltered (data not shown).
Discussion
To our knowledge, this is the first study to investigate the
relationship between the C242T polymorphism and the preva-
lence of metabolic syndrome in a Chinese population. Our main
findings were that the CT/TT genotypes of the C242T
polymorphism were associated with a lower risk of metabolic
syndrome and that smoking habit might modify this association.
The significant genotype-phenotype association was especially
marked in smokers who smoked no less than 25 pack-years.
In recent years, the C242T polymorphism of the CYBA gene
has been widely discussed in the context of cardiovascular diseases,
however, the results were conflicting [7,15–18]. The C242T
polymorphism of the CYBA gene that codes p22phox had been
found to modulate superoxide production. Functionally, superox-
ide production has been linearly associated with the C242T
genotypes, being highest in CC, and lower in CT/TT genotypes
[7]. Meanwhile, a latest meta-analysis conducted by Fang et al
[19] demonstrated that the T allele of the C242T polymorphism
was related to reduced CAD risk only in Asian population, which
indicated that differences in the ethnicity may cause disparities in
results. Accordingly, we also found a significant protective effect of
the T allele for metabolic syndrome in a Chinese population, and
such effect was mainly focused on serum concentration of
triglycerides. Several studies [20,21] had demonstrated that
triglyceride correlated strongly with leukocyte production of
reactive oxygen species (ROS). This might be due to oxidative
stress by the modification of lipoprotein. It is known that
perioxidized fatty acids can activate phospholipase A2 [22], which
may increase the release of arachidonic acid from leukocyte
membrane and therefore contribute to the activation of NADPH
oxidase.
Cigarette smoke contains many xenobiotics, including free
radicals and oxidants that can increase lipid peroxidation. One
previous study [23] indicated that cigarette smoke contains about
10
14 free radicals per inhalation. Specific biomarkers of lipid
peroxidation were reported to be associated with the number of
cigarettes smoked daily, with lipid peroxidation increasing with the
number of cigarettes smoked [24]. Increased superoxide produc-
tion that derived from smoking leads to the inactivation of nitric
oxide, thus contributing to endothelial dysfunction and predispos-
ing to the development of metabolic syndrome [25,26]. Since
membrane-associated NADPH oxidase is the primary physiolog-
ical producer of reactive oxygen species, including superoxide
[27], p22phox is the primary enzyme interface between environ-
mental oxidants and host organism, the genetic susceptibility
ascribable to this enzyme family is expected to be associated with
different dose levels of exposed xebobiotics. In the present study,
Figure 2. Difference of prevalence of metabolic syndrome between C242T genotypes in different smoking dose groups. The odds of
prevalence of metabolic syndrome in genotypic group is expressed relative to the participants in each smoking dose group, and adjusted for the
same covariates as in the Figure 1.
doi:10.1371/journal.pone.0031926.g002
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terms of C242T polymorphism of the CYBA gene, taking account
of consumed cigarette amounts. This indicates that the genetic
susceptibility ascribe to CYBA 242 C plays an important role in
occurrence of metabolic syndrome, especially in participants who
smoke greater than 25 pack-year. Similar results have been
reported by Fan et al [28], who found that the C242T
polymorphism of the CYBA gene was related to the brachial
artery FMD response in young healthy Finnish adults, and that
body adiposity and smoking status may modify this association.
Contrary to these findings, Niemiec et al [29] reported the 242T
allele interacted with cigarette smoking and hypercholesterolemia
to increase the risk of CAD and this risk is probably associated
with the cumulative/synergistic effect of the 242T allele and both
the traditional risk factors, however, some recent studies [30,31]
have failed to find any effect of the C242T polymorphism either
on venous endothelial function in healthy individuals or on
forearm endothelium-dependent vasodilatation in subjects with
hypercholesterolemia. Differences in vascular territories and
sample sizes may explain such discrepancies.
The components of the antioxidant defense system maintain the
levels of ROS in the normal cellular homeostatic range. That is,
under normal conditions this system reduces excess ROS to
minimize damage, yet still allows for ROS required in intracellular
redox signaling. However, certain pathological conditions, such as
NADPH oxidase activation, hyperglycemia, and hyperlipidemia,
have been shown to promote oxidative stress through elevated
ROS production and/or reduced antioxidant defense [32].
Several lines of evidence have suggested that fat accumulation is
correlated with high oxidative stress state in human populations
[33]. In consistent with these evidence,the present study revealed
that the CC genotype was related to larger waist circumference in
smokers, that may resulted from the excessive activation of
NADPH oxidase in smokers with elevated levels of oxidative stress
[34]. But the direct cause of this increase in waist circumference
with elevated oxidative stress is still not entirely clear.
The interaction by smoking might be potentially confounded by
gender-specificity for males were with more proportion of smoking
habit. However, the interaction terms between explanatory
variables and sex were non-significant, and similar results were
found in males compared to the whole subjects. Meanwhile, there
were also no statistical differences between genetic variations and
prevalence of metabolic syndrome after stratified by sex (data not
shown).
Our study had to be interpreted within the context of its
limitations. First, our study sample was not randomly selected or
general population, selection bias was possible. Although the
majority of smokers in our participants are male, it was in line with
the Chinese national condition [35] and previous WHO reports
(61% of men are reported to be current smokers in China
compared with only 4.2% of women) [36], and did not have major
influence over the main findings in present study. Second, we did
not directly measure the biochemical indices related to superoxide
production to verify our hypothesis. Third, the frequency of T
allele in Asian population is relatively small than non-Asian
population, so the relatively small sample size in the lower smoking
dose groups in T allele carriers may have limited the statistical
power. Fourth, we did not collect information on time of exposure
to tobacco snuff. Finally, since our study was cross-sectional, no
causal inference could be taken.
In conclusion, our study suggests that the prevalence of
metabolic syndrome is indeed related to the C242T gene
polymorphism in relation to the amount of cigarette inhalation.
However, the predicative value of smoking and C242T polymor-
phism for metabolic syndrome in the Chinese population remains
to be elucidated.
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Table 2. Multiple regression analysis of C242T genotypes.
Variables Genotypes All subjects Smokers Non-smokers
Mean ± SE
* P Mean ± SE
# P Mean ± SE
# P
Waist circumference (cm) CC 83.660.32 0.37 87.460.60 0.006 82.060.37 0.88
CT+TT 82.760.85 83.461.57 82.261.01
Systolic blood pressure (mm Hg) CC 132.360.55 0.95 134.160.99 0.27 131.660.66 0.39
CT+TT 132.661.47 137.462.59 130.061.77
Diastolic blood pressure (mm Hg) CC 86.260.34 0.58 88.860.65 0.38 85.260.40 0.79
CT+TT 86.860.91 91.161.71 84.961.07
Serum HDL cholesterol concentration
(mmol/L)
CC 1.2860.01 0.21 1.2360.03 0.17 1.3160.01 0.99
CT+TT 1.3260.03 1.3160.06 1.3160.03
LogTG concentration (mmol/L) CC 0.3260.02 0.04 0.4960.04 0.02 0.2560.02 0.65
CT+TT 0.2060.05 0.1160.12 0.2260.06
Serum glucose concentration (mmol/L) CC 5.7060.04 0.58 5.9260.09 0.46 5.6060.04 0.59
CT+TT 5.7760.11 6.0560.25 5.6760.12
HDL=high density lipoprotein.
LogTG=Log transformation of the triglycerides.
*Adjusted for sex, age, body height, body weight, antihypertensive medication, antidiabetic medication, current smoking, alcohol intake and heart rate.
#Adjusted for sex, age, body height, body weight, antihypertensive medication, antidiabetic medication, alcohol intake and heart rate.
doi:10.1371/journal.pone.0031926.t002
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